Sarepta Therapeutics, Inc. (SRPT) stock
SRPTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 12/3086% below fair value
$14.77−0.36 (-2.38%)
Close on Nov 17, 2026Market cap $1.56BP/E –Yield –
Sarepta Therapeutics market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Sarepta Therapeutics's market cap was $1.76B on Nov 11, 2026, against $2.24B a year earlier. Over the last 5 years it ranged from $1.57B to $14.93B, with a median of $8.13B.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $1.76B | -21.9% |
| 2025 | Dec 31, 2025 | $2.25B | -80.6% |
| 2024 | Dec 31, 2024 | $11.61B | +28.7% |
| 2023 | Dec 29, 2023 | $9.02B | -20.7% |
| 2022 | Dec 30, 2022 | $11.37B | +57.9% |
| 2021 | Dec 31, 2021 | $7.20B | -46.4% |
| 2020 | Dec 31, 2020 | $13.43B | +39.7% |
| 2019 | Dec 31, 2019 | $9.61B | +32.1% |
| 2018 | Dec 31, 2018 | $7.28B | +102.6% |
| 2017 | Dec 29, 2017 | $3.59B | +141.0% |
| 2016 | Dec 30, 2016 | $1.49B | -7.9% |
| 2015 | Dec 31, 2015 | $1.62B | +170.9% |
| 2014 | Dec 31, 2014 | $597.68M | -21.8% |
| 2013 | Dec 31, 2013 | $764.56M | +31.0% |
| 2012 | Dec 31, 2012 | $583.70M | +473.4% |
| 2011 | Dec 30, 2011 | $101.80M | -48.4% |
| 2010 | Dec 31, 2010 | $197.35M | – |
See a number that looks wrong?